Statement issued by the company (Announcement)<\/p>\n
March 11, 2026<\/p>\n
Fully cloud<\/i>\u2011<\/i>enabled solution designed to help healthcare organizations scale digital pathology adoption and workflows <\/i><\/p>\n
Royal Philips<\/a> <\/strong>(NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the expansion of its digital pathology portfolio with new cloud-enabled capabilities designed to help healthcare organizations scale digital diagnostics, improve productivity, and advance their transformation to fully digital workflows.<\/p>\n Philips IntelliSite Pathology Solution on HealthSuite\u00b9, powered by Amazon Web Services (AWS)<\/strong> is a fully cloud-enabled digital pathology solution that helps pathology laboratories adopt and scale digital workflows without the complexity of on-premise infrastructure. The platform helps to securely store, manage, and enable analysis of large volumes of high-resolution pathology images while allowing pathologists to access, review, and collaborate on cases from virtually anywhere.2<\/sup> By simplifying IT management and operations and supporting scalable data management and collaboration, the solution helps laboratories improve workflow efficiency and advance routine clinical use of digital pathology.<\/p>\n The cloud-enabled offering combines Philips\u2019 leadership in digital pathology with AWS\u2019 leading healthcare cloud infrastructure. In January 2026, Frost & Sullivan<\/strong><\/a> recognized Philips with the 2025 Global Enabling Technology Leadership Award in Digital Pathology<\/strong>, while AWS was named 2026 Best in KLAS for Public Cloud Infrastructure.<\/p>\n Healthcare organizations are under growing pressure to manage rising image volumes, address workforce shortages, and prepare for AI-enabled diagnostics. According to the Signify Research Digital Pathology \u2013 World 2025 report<\/a>, many pathology departments have yet to adopt digital pathology for routine clinical diagnosis and continue to operate hybrid environments where microscopes remain central to primary diagnosis.<\/p>\n Fully digital workflows can improve efficiency, enable collaboration and case review, enhance diagnostic consistency, and create structured data foundations that support quality improvement and scalable AI interoperability3<\/sup>. Philips\u2019 cloud\u2011enabled digital pathology offering supports secure, remote access to images, simplifies data management at scale2<\/sup>, while supporting enterprise integration4<\/sup> and AI\u2011enabled applications across health systems.<\/p>\n \u201cAs early adopters of digital pathology, we have already experienced the operational and clinical value of working in a fully digital environment,\u201d said Dr. Cordon-Cardo, Chair of the Department of Pathology, Molecular and Cell-Based Medicine at Mount Sinai Health System. \u201cAs our program matures, the ability to scale efficiently across sites and manage the growing volume of pathology data becomes increasingly important. A cloud\u2011enabled deployment reduces reliance on on\u2011premise infrastructure while providing the flexibility, performance, and scalability required for enterprise collaboration and AI integration. This represents an important next step in advancing our digital pathology strategy.”<\/p>\n Philips\u2019 digital pathology portfolio<\/a> includes FDA\u2011cleared<\/a> whole\u2011slide scanners<\/a>, an image management system<\/a>, archive services, and implementation and support services that help laboratories transition from analog to digital pathology workflows. With thousands of digital pathology users worldwide and a growing number of clinical sites going fully digital, Philips has built one of the largest installed bases.<\/p>\n \u201cBy combining scalable cloud innovation with deep domain expertise and end-to-end services, we partner with our customers throughout their transformation journey \u2013 from the first digital slide to fully connected ecosystems that help turn data into actionable insight for precision care,\u201d said Martijn Hartjes, Business Leader Clinical Informatics at Philips. \u201cSuccessful digital pathology adoption is not about technology alone, it\u2019s about reimagining how care teams access clinical data and collaborate across a health system.\u201d<\/p>\n Philips IntelliSite Pathology on HealthSuite is the newest addition to the Philips HealthSuite Integrated Diagnostics portfolio<\/a> \u2013 a rich suite of cloud-based diagnostic solutions, powered by AWS, and designed to connect data, integrate workflows, and embed AI across the diagnostic enterprise.4<\/sup><\/p>\n The portfolio brings together Philips\u2019 latest cloud innovations, architected to operate independently or connect across diagnostic domains.2<\/sup> Other key solutions include Image Management on HealthSuite featuring Web Diagnostic Viewer, Cardiovascular Workspace on HealthSuite, and advanced visualization and AI management capabilities. Together, these solutions help health systems enable data interoperability 4<\/sup>, across radiology, cardiology, and pathology, streamline diagnostic workflows, and support more coordinated, data-driven care.<\/p>\n Philips will showcase its expanded digital pathology portfolio at HIMSS 2026<\/a> (Las Vegas, March 9\u201312) and at USCAP 2026<\/a> (San Antonio, March 21\u201326).<\/p>\n 1<\/sup> PIPS on HealthSuite is work in progress and not available in the USA or any other jurisdiction. Future availability cannot be ensured. Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people\u2019s health and well-being through meaningful innovation. Philips\u2019 patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.<\/p>\n Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2025 sales of EUR 18 billion and employs approximately 64,800 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com\/newscenter<\/a>.<\/p>\nAdvancing digital pathology toward routine clinical practice<\/h2>\n
A proven foundation for digital pathology<\/h2>\n
Expanding the Philips HealthSuite Integrated Diagnostics portfolio<\/h2>\n
\n2<\/sup> Third party claims from AWS, which may not apply in all markets and may be updated from time to time. The functionalities and benefits of the solution depend on customer-specific configuration and use. Please contact your local Philips representative for (market) availability.
\n3<\/sup> AI interoperability with PIPS on HealthSuite is a work in progress, is not available in the United States or any other jurisdiction, and will initially be available only with Ibex AI. Future availability cannot be guaranteed. Ibex AI and the contextual launch of Ibex AI within PIPS are Research Use Only (RUO) in the United States.
\n4<\/sup> Not intended for diagnostic, monitoring or therapeutic purposes or in any other manner for regular medical practice.<\/p>\nFor further information, please contact:<\/b>\r\n\r\nAnna Hogrebe\r\nPhilips Global External Relations\r\nTel.: +1 416 270 6757\r\nE-mail: anna.hogrebe@philips.com<\/a><\/pre>\n
About Royal Philips<\/h2>\n
Attachment<\/h2>\n